Audeara Update

Audeara (ASX:AUA) has hit the holy grail of high-growth ASX small-caps. Operating cash-flow positive.

…Just.

We’re talking $356 thousand. 

We’re being a little bit cheeky here, since they did it on the back of a $1.22 million Research and Development tax refund. 

But, it’s still a sign that the company is heading in the right direction. Operating leverage is high, and revenue is growing rapidly. Add in a dash of time, and you’ve got a recipe for positive and growing cash-flow and profit.

We’ll discuss the financials and the looming catalysts a bit further on. 

If you haven’t read our initial write-up on AUA, we suggest you check it out first. It covers the business in more detail, as well as our thesis for the stock. 

You can check it out here.

So, let’s jump into the recent developments and how they’ve changed our thesis. 

Japan is now in play through a distribution agreement with Eyear System Inc. The deal requires Eyear to purchase initial minimum order quantities.

China is also gaining traction. The Eastech licensing pathway has progressed to first commercial purchase orders. 

More than just revenue, these orders show the deals have substance to them, and business partners are seeing something valuable in AUA’s tech. 

Audeara secured NMPA certification for its China hearing aid launch, which is basically the difference between ‘interesting story’ and ‘you can actually sell the thing.’ 

The business model is starting to widen.

The market still thinks of Audeara as a consumer product company. An upstart small ASX earphones producer taking on the giants in audio-tech. 

But the BIG opportunities are in the nooks and crannies that no one is paying attention to. 

The company’s hearing algorithm is a winning lottery ticket squished in between the couch cushions. 

The white label licensing orders are a fifty dollar note waiting patiently in the pocket of your winter jacket. 

The Optek agreement is the clearest example. 

Audeara’s AUAI algorithms are being licensed for integration into Optek system-on-chip platforms on a fee-per-chip basis. That’s the kind of embedded distribution that can scale fast if OEM brands get on board. 

Of course, it’s all speculative until those orders roll in.

But think about this. If one big brand – like Philips – chooses AUA’s algorithms for one of their headphone models, it could completely change the company’s trajectory.

This is still a micro-cap. Execution risk is still real. But the nature of the risk has changed. Deals are happening. Orders are flowing. 

It’s now not so much about ‘can they do it?’

It’s, ‘how quickly can they do it?’

Financials

Q2FY26 Update

The 2QFY26 quarterly report delivered a solid result. Revenue came in at $1.43 million, a 5.9% fall from Q1, but importantly a 274% increase on 2QFY25.

Combined with a $560 thousand purchase order to be recognised in Q3, it brings FY26 revenue to date to $3.5 million. 

This is a fantastic result. While the numbers might not look big, AUA made $3.8 million in revenue for the whole of FY25.

So, we’re seeing very strong growth in these numbers. 

The best part is, most of these new deals and offerings have barely started.

For 1HFY26 as a whole, we saw revenue of $2.95 million, a ~64% increase, or $1.15 million on 1HFY25. This excludes the big order to be recognised in 2HFY26.

Operating leverage is kicking in nicely. We previously commented that a $3 million increase in revenue should easily add $1 million to net profit. 

Well gross profit increased by 109% or $511 thousand to $980 thousand.

That’s a roughly 44% gross margin on incremental revenue. That suggests $2.3 million in revenue is required for $1 million in gross profit. The total gross margin for the half-year came in at 33.2%, up from 26% in 1HFY25. 

Let’s take a look at how that translates to the NPAT level. 

AUA is being extremely tight on the cost control front. There were no notable changes to the cost structure. 

It’s also worth noting that a substantial uplift in the R&D tax offset, rising by 53% to $572 thousand. There was also an additional government grant of $51 thousand. All up, ‘Other income’ increased by $252 thousand.

The NPAT loss has reduced to just $593 thousand, down 57% from $1.38 million. That’s $787 thousand lower.

That translates to a 68% marginal NPAT margin. Once we remove the change in ‘Other income’, the change is a more modest 33%.

That’s spot on $3 million additional revenue to bring in a further $1 million in NPAT, as we predicted.

While revenue is starting to punch out bigger numbers, it’s important to note that cash receipts lag revenue. For Q2, cash receipts came in low at $732 thousand. 

That brings us to the next important point.

Cash is King

In our initiation on Audeara, we identified the cash position as a primary risk for investors. 

Not that we think the company will close the doors. But, we anticipate a capital raise this year. But as we pointed out, a few more things going to plan, and it could be at a much higher share price. 

At the end of December, cash and cash equivalents sit at $737 thousand, down from $1.21 million in the prior quarter.

The company put $837 thousand net into loan repayments and loan fees. 

That $737 thousand is looking rather thin.